138 related articles for article (PubMed ID: 33320757)
41. [McCune-Albright syndrome revealed by Blaschko-linear café-au-lait spots on the back].
Jung AJ; Soskin S; Paris F; Lipsker D
Ann Dermatol Venereol; 2016 Jan; 143(1):21-6. PubMed ID: 26610360
[TBL] [Abstract][Full Text] [Related]
42. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.
Weinstein LS; Shenker A; Gejman PV; Merino MJ; Friedman E; Spiegel AM
N Engl J Med; 1991 Dec; 325(24):1688-95. PubMed ID: 1944469
[TBL] [Abstract][Full Text] [Related]
43. Denosumab use in bone fibrous dysplasia refractory to bisphosphonate: A retrospective multicentric study.
Trojani MC; Gensburger D; Bagouet F; Cortet B; Couture G; Marcelli C; Mehsen Cetre N; Breuil V; Chapurlat R
Bone; 2023 Sep; 174():116819. PubMed ID: 37301527
[TBL] [Abstract][Full Text] [Related]
44. Scoliosis in Fibrous Dysplasia/McCune-Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates.
Berglund JA; Tella SH; Tuthill KF; Kim L; Guthrie LC; Paul SM; Stanton R; Collins MT; Boyce AM
J Bone Miner Res; 2018 Sep; 33(9):1641-1648. PubMed ID: 29669167
[TBL] [Abstract][Full Text] [Related]
45. A boy with McCune-Albright syndrome associated with GH secreting pituitary microadenoma. Clinical findings and response to treatment.
Papadopoulou M; Doula S; Kitsios K; Kaltsas T; Kosta K
Hormones (Athens); 2006; 5(3):205-9. PubMed ID: 16950755
[TBL] [Abstract][Full Text] [Related]
46. Activating Gsalpha mutations: analysis of 113 patients with signs of McCune-Albright syndrome--a European Collaborative Study.
Lumbroso S; Paris F; Sultan C;
J Clin Endocrinol Metab; 2004 May; 89(5):2107-13. PubMed ID: 15126527
[TBL] [Abstract][Full Text] [Related]
47. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion.
Malchoff CD; Reardon G; MacGillivray DC; Yamase H; Rogol AD; Malchoff DM
J Clin Endocrinol Metab; 1994 Mar; 78(3):803-6. PubMed ID: 8126161
[TBL] [Abstract][Full Text] [Related]
48. Quantitative Correlations between Radiosensitivity Biomarkers Show That the ATM Protein Kinase Is Strongly Involved in the Radiotoxicities Observed after Radiotherapy.
Le Reun E; Bodgi L; Granzotto A; Sonzogni L; Ferlazzo ML; Al-Choboq J; El-Nachef L; Restier-Verlet J; Berthel E; Devic C; Bouchet A; Bourguignon M; Foray N
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142346
[TBL] [Abstract][Full Text] [Related]
49. Fibrous Dysplasia of Bone and McCune-Albright Syndrome: A Bench to Bedside Review.
Hartley I; Zhadina M; Collins MT; Boyce AM
Calcif Tissue Int; 2019 May; 104(5):517-529. PubMed ID: 31037426
[TBL] [Abstract][Full Text] [Related]
50. GNAS mutated thyroid carcinoma in a patient with Mc Cune Albright syndrome.
Legrand MA; Raverot G; Nicolino M; Chapurlat R
Bone Rep; 2020 Dec; 13():100299. PubMed ID: 32760762
[TBL] [Abstract][Full Text] [Related]
51. Surgical Treatment of Polyostotic Craniomaxillofacial Fibrous Dysplasia Associated With Acromegalia: The McCune - Albright Syndrome.
Franco JMPL; Rêgo RD; Gomes GMF; Santos DFDS; Santos ES
J Craniofac Surg; 2019 Sep; 30(6):1806-1808. PubMed ID: 31033754
[TBL] [Abstract][Full Text] [Related]
52. McCune-Albright syndrome: clinical picture and natural history in children and adolescents.
Völkl TM; Dörr HG
J Pediatr Endocrinol Metab; 2006 May; 19 Suppl 2():551-9. PubMed ID: 16789617
[TBL] [Abstract][Full Text] [Related]
53. Is McCune-Albright syndrome overlooked in subjects with fibrous dysplasia of bone?
Hannon TS; Noonan K; Steinmetz R; Eugster EA; Levine MA; Pescovitz OH
J Pediatr; 2003 May; 142(5):532-8. PubMed ID: 12756386
[TBL] [Abstract][Full Text] [Related]
54. Hypothyroidism in McCune-Albright Syndrome and Role of Bone Scan in Management of Fibrous Dysplasia: An Unusual Case Scenario with Review of Literature.
Kumar N; Kheruka SC; Singh RK; Ravina M; Dutta D; Gambhir S
Indian J Nucl Med; 2017; 32(1):25-29. PubMed ID: 28242980
[TBL] [Abstract][Full Text] [Related]
55. Melanotic macules following Blaschko's lines in McCune-Albright syndrome.
Rieger E; Kofler R; Borkenstein M; Schwingshandl J; Soyer HP; Kerl H
Br J Dermatol; 1994 Feb; 130(2):215-20. PubMed ID: 8123575
[TBL] [Abstract][Full Text] [Related]
56. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome.
Yamamoto T; Ozono K; Kasayama S; Yoh K; Hiroshima K; Takagi M; Matsumoto S; Michigami T; Yamaoka K; Kishimoto T; Okada S
J Clin Invest; 1996 Jul; 98(1):30-5. PubMed ID: 8690800
[TBL] [Abstract][Full Text] [Related]
57. Hepatobiliary and Pancreatic neoplasms in patients with McCune-Albright syndrome.
Gaujoux S; Salenave S; Ronot M; Rangheard AS; Cros J; Belghiti J; Sauvanet A; Ruszniewski P; Chanson P
J Clin Endocrinol Metab; 2014 Jan; 99(1):E97-101. PubMed ID: 24170100
[TBL] [Abstract][Full Text] [Related]
58. McCune-Albright syndrome: a detailed pathological and genetic analysis of disease effects in an adult patient.
Vasilev V; Daly AF; Thiry A; Petrossians P; Fina F; Rostomyan L; Silvy M; Enjalbert A; Barlier A; Beckers A
J Clin Endocrinol Metab; 2014 Oct; 99(10):E2029-38. PubMed ID: 25062453
[TBL] [Abstract][Full Text] [Related]
59. Short stature and growth hormone deficiency: unexpected manifestations of McCune-Albright syndrome.
Pina Rivera Y; Rwegerera GM; Sesay S
BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30150346
[TBL] [Abstract][Full Text] [Related]
60. Thyroid carcinoma in the McCune-Albright syndrome: contributory role of activating Gs alpha mutations.
Collins MT; Sarlis NJ; Merino MJ; Monroe J; Crawford SE; Krakoff JA; Guthrie LC; Bonat S; Robey PG; Shenker A
J Clin Endocrinol Metab; 2003 Sep; 88(9):4413-7. PubMed ID: 12970318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
